Advisors Preferred, LLC Gilead Sciences, Inc. Transaction History

Advisors Preferred, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 21, 2020	SELL	$61.62 - $67.78 $29,146 - $32,059	-473 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $6,063 - $6,693	97 Added 25.8%	473 $30,000
Q2 2019 Aug 06, 2019	BUY	$61.87 - $69.38 $23,263 - $26,086	376 New	376 $26,000
Q1 2019 May 03, 2019	SELL	$62.53 - $70.05 $30,264 - $33,904	-484 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$60.54 - $79.0 $29,301 - $38,236	484 New	484 $31,000
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $19,388 - $21,466	-272 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $102,510 - $119,574	-1,580 Reduced 85.31%	272 $19,000
Q1 2018 Apr 30, 2018	BUY	$72.84 - $88.8 $134,899 - $164,457	1,852 New	1,852 $140,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.